The incidence of aberrant endometrial αvβ3 vitronectin expression in a high risk infertility population: Could prolonged GnRH agonist therapy play a role?

Journal of Assisted Reproduction and Genetics

Volumn 24, Issue 11, 2007, Pages 553-556

  Surrey, Eric S ^a   Minjarez, Debra A ^a   Schoolcraft, William B ^a  

^a National Foundation for Fertility Research   (United States)

Author keywords

Endometriosis; GnRH agonist; Implantation; In vitro fertilization; Integrin

Indexed keywords

ALPHA V BETA3 VITRONECTIN; GONADORELIN AGONIST; INTEGRIN; UNCLASSIFIED DRUG; VITRONECTIN;

ADULT; ARTICLE; CONTROLLED STUDY; ENDOMETRIOSIS; FEMALE; FERTILIZATION IN VITRO; HUMAN; IMPLANTATION; INFERTILITY; MAJOR CLINICAL STUDY; OVARY HYPERSTIMULATION; PREGNANCY RATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY;

ADULT; CASE-CONTROL STUDIES; DANAZOL; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; HUMANS; INFERTILITY, FEMALE; INTEGRIN ALPHAVBETA3; LEUPROLIDE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 36849037950     PISSN: 10580468     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10815-007-9164-3     Document Type: Article

References (16)

1. Lessey B, Damjanovich L, Coutifaris C, Castelbaum A, Albelda S, Buck C. Integrin adhesion molecules in the human endometrium. Correlation with the normal and abnormal menstrual cycle. J Clin Invest 1992;90:188-95.
2. Lessey B, Castelbaum A, Buck C, Lei Y, Yowel C, Sun J. Further characterization of endometrial integrins during menstrual cycle and in pregnancy. Fertil Steril 1994;67:497-506.
3. Campbell S, Swann H, Seif M, Kimber S, Aplin J. Cell adhesion molecules on the oocyte and preimplantation human embryo. Hum Reprod 1995;10:1571-8.
4. Lindhard A, Beutin-Ley U, Raun V, Islin H, Hoiid T, Rex S, et al. Biochemical evaluation of endometrial function at the time of implantation. Fertil Steril 2002;78:221-33.
5. Creus M, Ordi J, Fabregios F, Casainjana R, Carmona F, Cardesa A, et al. The effect of different hormone therapies on integrin expression and pinopode formation in the human endometrium: a controlled study. Hum Reprod 2003;18:683-93.
6. Lessey B, Castelbaum A, Sawin S, Sun J. Integrins as markers of uterine receptivity in women with primary unexplained infertility. Fertil Steril 1995;63:535-42.
7. Lessey B, Castelbaum A, Sawin S, Buck C, Schinnar R, Bilker W, et al. Aberrant integrin expression in the endometrium of women with endometriosis. J Clin Endocrinol Metab 1994;79:643-9.
8. 3 in women with and without endometriosis. Hum Reprod 1998;13:1030-5.
9. 3 integrin expression is not impaired in women with endometriosis. J Assist Reprod Genet 2003;20:465-73.
10. Thomas K, Thomson A, Wood S, Kingsland C, Vince G, Lewis-Jones J. Endometrial integrin expression in women undergoing in vitro fertilization and the association with subsequent treatment outcome. Fertil Steril 2003;80:502-7.
11. Wolz-Lopez A, Williams A, Russell J, Schwarz S. Should e-tegrity testing be an integral part of a complete in-vitro fertilization (IVF) work-up? Fertil Steril 2004;82 Suppl 2:S12-3 (Abstr.O-31)
12. Lessey B. Medical management of endometriosis and infertility. Fertil Steril 2000;73:1089-96.
13. 3 integrin in the endometrium of unexplained infertility patients with recurrent IVF-ET failures: improvement by danazol treatment. J Assist Reprod Genet 2003;20:13-20.
14. Sallam H, Garcia-Velasco J, Dias S, Arici A. Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis. Cochrane Database Syst Rev 2006;(1), Art no. CD004635. DOI 10.1002/14651858.CD004635.pub2
15. Surrey E, Silverberg K, Surrey M, Schoolcraft W. Effect of prolonged gonadotropin-releasing hormone agonist therapy or the outcome of in vitro fertilization embryo transfer in patients with endometriosis. Fertil Steril 2002;78:699-704.
16. Gardner D, Schoolcraft W, Wagley L, Schlenker T, Stevens J, Hesla J. A prospective randomized trial of blastocyst culture and transfer in in vitro fertilization. Hum Reprod 1998;13:3434-40.